M.D. Sass LLC’s Synopsys SNPS Stock Holding History

M.D. Sass LLC’s Portfolio SNPS Stock Details SNPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-76,822	Closed	-$30.5M	–	46
2026 Q1	$30.5M	Buy	+76,822	New	+$34.7M	2.31%	22

Other funds holding SNPS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nvidia Corp Santa Clara, California $63.4B AUM 136.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

M.D. Sass LLC's SNPS Position: Q2 2026 in Review

M.D. Sass LLC sold out of Synopsys (SNPS) in Q2 2026, closing a stake of 76,822 shares — an estimated $30.5M sold.

M.D. Sass LLC first reported a position in SNPS in Q1 2026 and held it in 1 quarter. The position peaked at $30.5M in Q1 2026. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

M.D. Sass LLC reported no remaining Synopsys position as of Q2 2026 after selling out during the quarter.
M.D. Sass LLC sold 76,822 Synopsys shares in Q2 2026, an estimated $30.5M.
M.D. Sass LLC first reported a position in Synopsys in Q1 2026 and held it in 1 quarter.
M.D. Sass LLC's Synopsys position peaked at $30.5M in Q1 2026.
1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on M.D. Sass LLC's 13F filing for Q2 2026, filed 7 Aug 2026.